The case for eggshell-derived hydroxyapatite is usually argued in a laboratory. It is cheaper. It valorises a waste stream. Its trace chemistry sits closer to biological apatite than a reagent-grade synthetic does.
All of which is interesting, and none of which is the question a surgeon asks. The question a surgeon asks is whether bone comes back.
Two grafts, one defect type
In 2025, Changani, Managutti, Menat, Patel, Kattimani, Panchal and Girija published a study in the Journal of Oral Biology and Craniofacial Research comparing eggshell-derived hydroxyapatite against synthetic hydroxyapatite in the regeneration of maxillofacial defects.
The eggshell material was made the way the current literature makes it: hen’s eggshells washed and calcined to calcium oxide, mixed with 0.5 M diammonium hydrogen phosphate at a Ca/P ratio of 1.67, then formed under microwave irradiation at 800 W. Before it went anywhere near a patient it took 25 kGy of gamma irradiation for sterilisation.
That last detail is not incidental, and readers of this blog will recognise why. Sterilisation is a processing step that can change a calcium phosphate — so whatever was measured in this study was measured on post-irradiation material, which is the honest place to measure it.
What the numbers said
At six months and at one year, bone density in the eggshell arm ran ahead of the synthetic arm: 136.04 ± 15.56 against 115.58 ± 16.26, a difference the authors report as statistically significant.
And yet their conclusion opens with equivalence: “Both EHA and SHA graft materials are equally efficient in early bone regeneration. The EHA showed promising results and enhanced bone regeneration with osteoconductivity.”
Both halves of that sentence are doing work. Early on, the two materials behave the same. Later, they separate. A claim built on the first half is a claim about interchangeability; a claim built on the second is a claim about superiority at twelve months. They are not the same claim, and a specification sheet that quotes one while implying the other is overreaching.
The part that does not travel
Here is the limit worth stating plainly. This result belongs to that eggshell-derived material — that calcination, that Ca/P ratio, that microwave route, that gamma dose — and not to eggshell-derived hydroxyapatite as a category.
The trace elements that make biogenic apatite interesting are inherited from the shell, and shells vary with flock, feed and region. The phase composition is decided by the synthesis route. The surface is decided by what sterilisation did to it. Change any of those and you have a material with the same name and a different biological argument.
So the finding is genuinely good news for the category, and it is not transferable evidence for any particular drum of powder. What makes it transferable is a supplier who can show that their route, their ratio and their sterilisation are the same ones every time — which is, once again, the whole question.
Sources
Changani, Managutti, Menat, Patel, Kattimani, Panchal, Girija. “Evaluating the efficacy of eggshell-derived hydroxyapatite (EHA) and synthetic hydroxyapatite (SHA) in bone regeneration of maxillofacial defects.” Journal of Oral Biology and Craniofacial Research, 2025 (open access) — pmc.ncbi.nlm.nih.gov/articles/PMC12804149.